loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Marketing Authorisations (MA) containing NCGC00024584-03 in Europe. Original Data : EMA Website

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 MEDA PHARMA SpA (3)

02 Meda - Asker (1)

03 Orifarm AS (2)

04 TEVA ITALIA Srl (1)

filter

01 Bromocriptine (7)

filter

01 Antic-calc Tablet (3)

02 Bromocriptina 10Mg 20 Joined' Oral Use (1)

03 Bromocriptina 2,5Mg 30 Joined' Oral Use (2)

04 Bromocriptina 5Mg 30 Joined' Oral Use (1)

filter

01 Italy (4)

02 Norway (3)

filter

01 Bromocriptina (1)

02 Parlodel (6)

URL Supplier Web Content
Bromocriptina 2,5Mg 30 Joined' Oral Use
30 CPR 2.5 mg
Parlodel
Italy
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Bromocriptina 5Mg 30 Joined' Oral Use
30 cps 5 mg
Parlodel
Italy
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Bromocriptina 10Mg 20 Joined' Oral Use
20 cps 10 mg
Parlodel
Italy
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Antic-calc Tablet
2.5 mg
Parlodel
Blister
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Antic-calc Tablet
2.5 mg
Parlodel
Blister
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Bromocriptina 2,5Mg 30 Joined' Oral Use
30 CPR 2.5 mg
Bromocriptina
Italy
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Meda - Asker

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
Antic-calc Tablet
2.5 mg
Parlodel
Box
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY